heptex
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 8, 2019 (NCT05343780)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
NFKB1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05343780 | Phase 2 | May 8, 2019 | Ain Shams University, National Hepatology & Tropical Medicine Research Institute, Natural Wellness Egypt |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ain Shams University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| National Hepatology & Tropical Medicine Research Institute | Government | 1 | 0 | 1 | 2019 |
| Natural Wellness Egypt | Academic/Hospital | 1 | 1 | 1 | 2019 |
3 organizations
Page 1 / 1